When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ABBV - Myovant conference call tomorrow on late-stage study of relugolix in prostate cancer
AbbVie Inc.
Myovant Sciences (NYSE:MYOV) will host a conference call tomorrow, November 19, at 8:30 am ET to discuss results from a Phase 3 clinical trial, HERO, evaluating oral relugolix in men with advanced prostate cancer.
More news on: Myovant Sciences Ltd., AbbVie Inc., Healthcare stocks news, Stocks on the move,